Download PDF
J Reconstr Microsurg 2005; 21(8): 555-564
DOI: 10.1055/s-2005-922436
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Role of Blood Transfusion in Transplantation: A Review

Maria Siemionow1 , Galip Agaoglu1
  • 1Department of Plastic Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio
Further Information

Publication History

Accepted: July 14, 2005

Publication Date:
17 November 2005 (online)

Also available at
    Permissions and Reprints

ABSTRACT

The ultimate goal of transplantation immunology is induction of donor-specific tolerance without the need for chronic immunosuppression. A number of strategies have been used to induce tolerance, including donor-specific blood transfusion (DST). A large number of experimental and clinical studies have evaluated the ability of DST to induce tolerance in solid organ transplantation. In contrast, a limited number of experimental studies have been reported evaluating the effect of DST in induction of tolerance in composite tissue allograft transplants.

DST applications include cadaveric and living-related graft recipients in humans, leading to achievement of microchimerism. Although the mechanism of action is still uncertain, microchimerism with the concomitant persistence of soluble donor HLA antigen is considered to be the most significant contributing factor.

In this article, the experimental and clinical applications, as well as the immunomodulatory mechanism of DST, are reviewed.

KEYWORDS

Donor-specific blood transfusion - composite tissue allograft - tolerance strategies

REFERENCES

  • 1 Opelz G, Sengar D P, Mickey M R, Terasaki P I. Effect of blood transfusions on subsequent kidney transplants.  Transplant Proc. 1973;  5 253-259
    PubMedGoogle Scholar
  • 2 Brynger H, Frisk B, Ahlmen J. Graft survival and blood transfusion. In: Robinson BH Proceedings of the XIV Congress of the European Dialysis and Transplant Association. Kent, England; Pitman Medical Publishing Co 1997: 290-295
    Google Scholar
  • 3 Pfaff W W, Fennell R S, Howard R J. Planned random donor blood transfusion in preparation for transplantation.  Transplantation. 1984;  38 701-703
    PubMedGoogle Scholar
  • 4 Okazaki H, Maki T, Wood M L. Effect of blood transfusions on skin allograft survival in immunosuppressed mice.  Transplant Proc. 1981;  13 515-517
    PubMedGoogle Scholar
  • 5 Frisk B, Brynger H, Sandberg L. Two random transfusions before primary renal transplantation-four years experience from a single center.  Transplant Proc. 1982;  14 386-388
    PubMedGoogle Scholar
  • 6 Faver C, Jeannet M, Harder F. Blood transfusions, cytotoxic antibodies, and kidney graft survival.  Transplantation. 1979;  28 343-346
    PubMedGoogle Scholar
  • 7 Salvatierra O, Vincenti F, Ahmend W J. What about blood transfusions in living related transplantation? Abstracts of the American Society of Nephrology, Twelfth Annual Meeting. Boston, Massachusetts; 1979: 178A
    Google Scholar
  • 8 Kerman R H, Susskind B, Katz S M, Van Buren C T, Kahan B D. Post renal transplant MLR hypo-responders have fewer rejections and better graft survival than MLR hyper-responders.  Transplant Proc. 1997;  29 1410-1411
    CrossrefPubMedGoogle Scholar
  • 9 Kerman R H, Katz S M, Schoenberg L, Baraket O, Van Buren C T, Kahan B D. 10-year follow up of MLR-hyporesponsive living related cyclosporine monotherapy treated renal allograft recipients.  Transplant Proc. 1997;  29 198-199
    CrossrefPubMedGoogle Scholar
  • 10 Jackson A, McSherry C, Butters K et al.. Pretransplant exposure to donor HLA-DR antigen in random transfusion units and the development of donor antigen-specific hyporeactivity.  Human Immunology. 1997;  55 148-153
    CrossrefPubMedGoogle Scholar
  • 11 Salvatierra O, Vincenti F, Amend W et al.. Deliberate donor-specific blood transfusions prior to living related renal transplantation: a new approach.  Ann Surg. 1980;  192 544
    PubMedGoogle Scholar
  • 12 Opelz G, Terasaki P I. Dominant effect of transfusions on kidney graft survival.  Transplantation. 1980;  29 153-158
    PubMedGoogle Scholar
  • 13 Salvatierra O, Vincenti F, Ahmend W JC. Four year experience with donor-specific blood transfusions.  Transplant Proc. 1983;  15 924
    PubMedGoogle Scholar
  • 14 Potter D, Garovoy M, Hopper S et al.. Effect of donor specific transfusion on renal transplantation.  Pediatrics. 1985;  76 402-405
    PubMedGoogle Scholar
  • 15 Broyer M, Gagnadoux M, Guest G et al.. Kidney transplantation in children: results of 383 grafts performed at Enfants Malades Hospital from 1973-1984. In: Hamgurger J, Grosnier J, Grunfeld P, Maxwell MD Advances in Nephrology. Chicago, IL; Year Book Medical Publishers 1987 307
    Google Scholar
  • 16 Chavers B M, Nevins T E, Knaack M et al.. Early acute tubular necrosis, late rejection in pediatric renal transplantation with donor specific transfusion.  Transplant Proc. 1987;  19 1526-1527
    PubMedGoogle Scholar
  • 17 Kahan B D, Van Buren C T, Flechner S M, Payne W D, Boileau M, Kerman R H. Cyclosporine immunosuppression mitigates immunologic risk factors in renal allotransplantation.  Transplant Proc. 1983;  15 2469-2478
    PubMedGoogle Scholar
  • 18 Lundgren G, Albrechtsen D, Flatmark A et al.. HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation-a changing picture with cyclosporin.  Lancet. 1986;  2 66-69
    PubMedGoogle Scholar
  • 19 Opelz G. Improved kidney graft survival in nontransfused recipients.  Transplant Proc. 1987;  19 149-152
    PubMedGoogle Scholar
  • 20 Cecka J M, Cicciarelli J, Mickey M R, Terasaki P I. Blood transfusions and HLA matching-an either/or situation in cadaveric renal transplantation.  Transplantation. 1988;  45 81-86
    PubMedGoogle Scholar
  • 21 Dubernard J M, Owen E, Herzberg G et al.. Human hand allograft: report on first 6 months.  Lancet.. 1999;  353 1315-1320
    CrossrefPubMedGoogle Scholar
  • 22 Siemionow M, Gozel-Ulusal B, Engin Ulusal A et al.. Functional tolerance following face transplantation in the rat.  Transplantation.. 2003;  75 1607-1609
    PubMedGoogle Scholar
  • 23 Siemionow M, Oke R, Ozer K et al.. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol.  J Hand Surg. 2002;  27A 1095-1103
    PubMedGoogle Scholar
  • 24 Buttemeyer R, Jones N F, Min Z et al.. Rejection of the component tissues of limb allografts in rats immunosuppressed with FK-506 and cyclosporine.  Plast Reconstr Surg. 1996;  97 139-148
    PubMedGoogle Scholar
  • 25 Kamel G, Stephan A, Masri M A et al.. Donor-specific transfusion under the new cyclosporine A formulation Consupren versus azathioprine, Imuran.  Transplant Proc. 1997;  29 2960-2961
    CrossrefPubMedGoogle Scholar
  • 26 Whelchel J D, Shaw J F, Curtis J J, Luke R G, Diethelm A G. Effect of pretransplant stored donor-specific blood transfusions on early renal allograft survival in one-haplotype living related transplants.  Transplantation. 1982;  34 326-329
    PubMedGoogle Scholar
  • 27 Cheigh J S, Suthanthiran M, Fotino M et al.. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.  Transplant Proc. 1991;  23 1023
    PubMedGoogle Scholar
  • 28 Otsuka M, Yuzawa K, Takada Y et al.. Long-term graft survival of living-related kidneys after donor-specific transfusion.  Transplant Proc. 2000;  32 1741-1742
    CrossrefPubMedGoogle Scholar
  • 29 Black K S, Hewitt C W, Woodard T L et al.. Efforts to enhance survival of limb allografts by prior administration of whole blood in rats using a new survival end-point.  J Microsurg. 1982;  3 162-167
    PubMedGoogle Scholar
  • 30 Balshi J D, Francfort J W, Perloff L J. The influence of ultraviolet irradiation on the blood transfusion effect.  Surgery. 1985;  98 243-250
    PubMedGoogle Scholar
  • 31 Lasek W, Jakóbisiak M, Plodzisewska M, Szczytnicki W, Górecki D. The role of drug timing and histoincompatibility barrier in prolongation of cardiac graft survival in mice treated with donor-specific blood and cyclophosphamide.  Immunology Letters. 1988;  17 357-360
    CrossrefPubMedGoogle Scholar
  • 32 Bradley J A. The blood transfusion effect: experimental aspects.  Immunology Letters. 1991;  29 127-132
    CrossrefPubMedGoogle Scholar
  • 33 Sato K, Yabuki K, Haba T, Maekawa T. Role of Kupffer Cells in the induction of tolerance after liver transplantation.  J Surg Res. 1996;  63 433-438
    CrossrefPubMedGoogle Scholar
  • 34 Sato Y, Farges O, Buffello D, Hatakeyama K, Bismuth H. Cytokine mRNA expression in the liver after administration of donor leukocytes.  Transplant Proc. 1998;  30 3855-3857
    CrossrefPubMedGoogle Scholar
  • 35 Antoniou E A, Drayson M, Howie A J, McMaster P, D'Silva M. Effect of donor-specific transfusion in combination with FK506 in rat cardiac allotransplantation.  Transplant Proc. 1999;  31 2796-2798
    CrossrefPubMedGoogle Scholar
  • 36 Morin N, Lamoureux E, Lipman M, Tector J, Tchervenkov J I, Metrakos P. Donor-specific portal transfusion augments microchimerism in a porcine model of small bowel transplantation.  Transplant Proc. 2000;  32 1290-1291
    CrossrefPubMedGoogle Scholar
  • 37 Fecteau A H, Tchervenkov J I, Guttman F M, Takara T, Rosenmann E. Small bowel transplantation: the effect of intraportal donor-specific transfusion 24 hours pretransplant and low-dose cyclosporine Transplantation.  1994;  58 399-402
    PubMedGoogle Scholar
  • 38 Martinelli G P, Chung-Loy R, Sher L. Long-term prolongation of cardiac allografts by subtherapeutic levels of cyclosporine in rats conditioned with pretransplant blood transfusions and cyclosporine.  Transplantation. 1985;  39 1-5
    PubMedGoogle Scholar
  • 39 Yasumura T, Kahan B D. Prolongation of rat kidney allografts by pretransplant administration of donor antigen extract or whole blood transfusion combined with a short course of cyclosporine.  Transplantation. 1983;  36 603-609
    PubMedGoogle Scholar
  • 40 Ahmed S M, Baslaim G, Eshelby D, Guttmann R D, Tchervenkov J I. The effect of transfusion with donor-specific peripheral lymphocytes, whole blood or erythrocytes on cardiac allograft survival in cyclosporine-treated rats.  Transplantation. 1994;  57 634-637
    PubMedGoogle Scholar
  • 41 Ringers J, Ossevoort M, Haanstra K, Kroczek R, Volk D, Jonker M. Blockade of CD154 at the time of donor-specific blood transfusion does not improve kidney graft survival in rhesus monkeys.  Transplant Proc. 2001;  33 524
    CrossrefPubMedGoogle Scholar
  • 42 Antoniou E A, Drayson M, Howie A J, McMaster P, D'Silva M. Donor-specific blood transfusion does not enhance the effect of FTY720 in rat cardiac allotransplantation.  Transplant Proc. 1998;  30 1042-1043
    CrossrefPubMedGoogle Scholar
  • 43 Oluwole S F, Fawwaz R A, Reemtsma K, Hardy M A. Induction of donor-specific unresponsiveness to rat cardiac allograft by donor leukocytes and cyclosporine.  Transplantation. 1988;  45 1131-1135
    PubMedGoogle Scholar
  • 44 Kahan B D. Cosmas and Damian revisited.  Transplant Proc. 1983;  15 2211-2216
    PubMedGoogle Scholar
  • 45 Lapchinsky A G, Eingorn A G, Uratkov E F. Homotransplantation of extremities in tolerant dogs observed up to seven years.  Transplant Proc. 1973;  5 773-779
    PubMedGoogle Scholar
  • 46 Kim S K, Aziz S, Oyer P, Hentz V R. Use of cyclosporin A in allotransplantation of rat limbs.  Ann Plast Surg. 1984;  12 249-255
    PubMedGoogle Scholar
  • 47 Stark G B, Swartz W M, Narayanan K, Moller A R. Hand transplantation in baboons.  Transplant Proc. 1987;  19 3968-3971
    PubMedGoogle Scholar
  • 48 Daniel R K, Egerszegi E P, Samulack D D, Skanes S E, Dykes R W, Rennie W R. Tissue transplants in primates for upper extremity reconstruction: a preliminary report.  J Hand Surg. 1986;  11 1-8
    PubMedGoogle Scholar
  • 49 Hotokebuchi T, Arai K, Takagishi K, Arita C, Sugioka Y, Kaibara N. Limb allografts in rats immunosuppressed with cyclosporine: as a whole-joint allograft.  Plast Reconstr Surg. 1989;  83 1027-1038
    PubMedGoogle Scholar
  • 50 Kniha H, Randzio J, Gold M E et al.. Growth of forelimb allografts in young rabbits immunosuppressed with cyclosporine.  Ann Plast Surg. 1989;  22 135-141
    PubMedGoogle Scholar
  • 51 Xu H, Montgomery S P, Preston E H et al.. Studies investigating pretransplant donor-specific blood transfusion, rapamycin, and the CD154-specific antibody IDEC-131 in a nonhuman primate model of skin allotransplantation.  J Immunol.. 2003;  170 2776-2782
    PubMedGoogle Scholar
  • 52 Nomoto K, Kanoh K, Suzuki H, Shimura T, Kuwano H. Mechanism of hyporesponsiveness caused by donor-specific transfusion to allogeneic minor antigens.  Eur Surg Res.. 2001;  33 217-224
    CrossrefPubMedGoogle Scholar
  • 53 Barbari A, Stephan A, Masri M A, Joubran N, Dagher O, Kamel G. Donor specific transfusion in kidney transplantation: effect of different immunosuppressive protocols on graft outcome.  Transplant Proc. 2001;  33 2787-2788
    CrossrefPubMedGoogle Scholar
  • 54 Kong J M, Jeong J H, Kang J K, Seong I G, Kim B C. Donor-specific transfusion in living related and unrelated donor kidney transplantation: minimal sensitization and excellent graft outcome.  Transplant Proc. 1995;  27 1036-1037
    PubMedGoogle Scholar
  • 55 Sharma R K, Pai P K, Kumar A et al.. Morphological and morphometric studies on liver in rats subjected to repetitive heat stress.  Nephron. 1997;  75 20-26
    PubMedGoogle Scholar
  • 56 Woodle E S, Newell K A, Haas M et al.. Reversal of accelerated renal allograft rejection with FK506.  Clin Transplant. 1997;  11 251-254
    PubMedGoogle Scholar
  • 57 Lyne J C, Vivas C A, Shapiro R et al.. Cadaveric renal transplantation against a positive crossmatch under tacrolimus immunosuppression: long-term follow-up.  Transplant Proc. 1997;  29 312
    CrossrefPubMedGoogle Scholar
  • 58 Sato Y, Watanabe H, Yamamoto S et al.. Role of recipient CD56+ CD3+ cells in the graft in living-related partial liver transplantation.  Transplant Proc. 2000;  32 2131-2132
    CrossrefPubMedGoogle Scholar
  • 59 Terasaki P I, Cecka J M, Gjertson D W, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors.  N Engl J Med. 1995;  333 333-336
    CrossrefPubMedGoogle Scholar
  • 60 Okazaki H, Sato T, Miura S, Amada N. Donor-specific blood transfusion in living-related renal transplantation: fourteen-year experience.  Transplant Proc. 1997;  29 200-202
    CrossrefPubMedGoogle Scholar
  • 61 Miura S, Okazaki H, Satoh T, Amada N, Ohashi Y. Long-term follow-up of living donor renal transplant recipients sensitized after donor specific blood transfusion.  Transplant Proc. 2001;  33 1221-1223
    CrossrefPubMedGoogle Scholar
  • 62 Chen D, Sung R, Bromberg J S. Gene therapy in transplantation.  Transplant Immunology. 2000;  9 301-314
    PubMedGoogle Scholar
  • 63 Liang J, Yamaguchi Y, Matsuda T et al.. Posttransplant infusion of donor-specific blood induces immunological unresponsiveness in rat hepatic allografts.  Transplantation. 2000;  70 1363-1371
    PubMedGoogle Scholar
  • 64 Marquet R L, Heystek G A. Induction of suppressor cells by donor-specific blood transfusions and heart transplantation in rats.  Transplantation. 1981;  31 272-274
    PubMedGoogle Scholar
  • 65 Terasaki P I. The beneficial transfusion effect on kidney graft survival attributed to clonal deletion.  Transplantation. 1984;  37 119-125
    PubMedGoogle Scholar
  • 66 Wendel T D. The beneficial effect of donor-specific transfusions: a review of existing explanations and a new hypothesis based on a relatively unapplied theory of T cell immunoregulation. A regulatory hypothesis in progress.  Med Hypotheses.. 2000;  54 922-943
    CrossrefPubMedGoogle Scholar
  • 67 Leivestad T, Thorsby E. Effects of HLA-haploidentical blood transfusions on donor-specific immune responsiveness.  Transplantation. 1984;  37 175-181
    PubMedGoogle Scholar
  • 68 Suciu-Foca N, Reed E, Rohowsky C, Kung P, King D W. Anti-idiotypic antibodies to anti-HLA receptors induced by pregnancy.  Proc Natl Acad Sci USA. 1983;  80 830-834
    PubMedGoogle Scholar
  • 69 Kishimoto K, Yuan X, Auchincloss Jr H, Sharpe A H, Mandelbrot D A, Sayegh M H. Mechanism of action of donor-specific transfusion in inducing tolerance: role of donor MHC molecules, donor co-stimulatory molecules, and indirect antigen presentation.  J Am Soc Nephrol. 2004;  15 2423-2428
    CrossrefPubMedGoogle Scholar
  • 70 Roelen D L, van Rood J J, Brand A, Claas F H. Immunomodulation by blood transfusions.  Vox Sang. 2000;  78 Suppl 2 273-275
    PubMedGoogle Scholar
  • 71 Roelen D, Brand A, Claas F H. Pretransplant blood transfusions revisited: a role for CD(4+) regulatory T cells?.  Transplantation. 2004;  77(1 Suppl) S26-S28
    PubMedGoogle Scholar
  • 72 Burlingham W J, Grailer A P, Fechner J H et al.. Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient.  Transplantation. 1995;  59 1147-1155
    PubMedGoogle Scholar
  • 73 Mincheff M S, Meryman H T, Kapoor V et al.. Blood transfusion and immunomodulation: A possible mechanism.  Vox Sang. 1993;  65 18-24
    PubMedGoogle Scholar
  • 74 Macleod A M, Hillis A N, Mather A, Bone J M, Catto G R. Effect of cyclosporin, previous third-party transfusion, and pregnancy on antibody development after donor-specific transfusion before renal transplantation.  Lancet. 1987;  329 416-418
    CrossrefPubMedGoogle Scholar
  • 75 Horuzsko A, Gyó E, Réti M et al.. Non-cytotoxic blocking antibodies and suppressor cells induced by donor-specific transfusions in healthy volunteers and potential kidney transplant recipients.  Immunology Letters. 1990;  26 127-130
    CrossrefPubMedGoogle Scholar
  • 76 Josien R, Douillard P, Guillot C et al.. A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance.  J Clin Invest. 1998;  102 1920-1926
    PubMedGoogle Scholar
  • 77 Lagaaij E L, Hennemann I P, Ruigrok M et al.. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts.  N Engl J Med. 1989;  321 701-705
    PubMedGoogle Scholar
  • 78 Mast B J, Balk A H. Effect of HLA-DR-shared blood transfusion on the clinical outcome of heart transplantation.  Transplantation.. 1997;  63 1514-1519
    PubMedGoogle Scholar
  • 79 Starzl T E, Demetris A J, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance.  Lancet. 1992;  339 1579-1582
    CrossrefPubMedGoogle Scholar
  • 80 Starzl T E, Demetris A J, Trucco M et al.. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance.  Hepatology. 1993;  17 1127-1152
    CrossrefPubMedGoogle Scholar
  • 81 Murase N, Starzl T E, Ye Q et al.. Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation: with particular reference to the liver.  Transplantation. 1996;  61 1-4
    PubMedGoogle Scholar
  • 82 Taniguchi H, Toyoshima T, Fukao K, Nakauchi H. Presence of hematopoietic stem cells in the adult liver.  Nat Med. 1996;  2 198-203
    PubMedGoogle Scholar
  • 83 Schlitt H J, Kanehiro H, Raddatz G et al.. Persistence of donor lymphocytes in liver allograft recipients.  Transplantation. 1993;  56 1001-1007
    PubMedGoogle Scholar
  • 84 Demetris A J, Murase N, Starzl T E. Donor dendritic cells after liver and heart allotransplantation under short term immunosuppression.  Lancet. 1992;  339 1610-1611
    PubMedGoogle Scholar
  • 85 Claas F. Towards clinical transplantation tolerance.  Lancet. 2003;  361 1489-1490
    CrossrefPubMedGoogle Scholar
  • 86 Fandrich F, Lin X, Zhu X, Kloppel G, Parwaresch R, Kremer B. CD95L confers immune privilege to liver grafts which are spontaneously accepted.  Transplant Proc. 1998;  30 1057-1058
    CrossrefPubMedGoogle Scholar
  • 87 Sharland A, Shastry S, Wang C et al.. Kinetics of intragraft cytokine expression, cellular infiltration, and cell death in rejection of renal allografts compared with acceptance of liver allografts in a rat model.  Transplantation. 1998;  65 1370-1377
    PubMedGoogle Scholar
  • 88 Shirwan H, Wang C, Barwari L, Cramer D V. Recipient-donor microchimerism is not a prerequisite for the maintenance of allograft tolerance.  Transplant Proc. 1997;  61 1182-1183
    PubMedGoogle Scholar
  • 89 Sivasai K SR, Alevy Y G, Duffy B F et al.. Peripheral blood microchimerism in human liver and renal transplant recipients.  Transplantation. 1997;  64 427-432
    CrossrefPubMedGoogle Scholar
  • 90 Ito H, Hamano K, Gohra H et al.. Role of microchimerism on long-term graft survival after donor-specific transfusion in a rat heart transplantation model.  Transplant Proc. 1998;  30 3862-3864
    CrossrefPubMedGoogle Scholar
  • 91 Huang Y, Xia J, Yang C, Ye S, Ye Y. IL-10 gene expression and cardiac allograft survival with or without treatment of monoclonal antibodies, CsA, donor-specific transfusion after rat heart transplantation.  J Heart Lung Transplant. 2002;  21 129
    PubMedGoogle Scholar
  • 92 Kataoka M, Margenthaler J A, Ku G, Flye M W. Development of infectious tolerance after donor-specific transfusion and rat heart transplantation.  J Immunol.. 2003;  171 204-211
    PubMedGoogle Scholar
  • 93 Ichiguchi O, Yamaguchi Y, Akizuki E et al.. Prolonged survival of rat hepatic allografts treated with a pretransplant donor-specific blood transfusion is associated with reduced cytokine-induced neutrophil chemoattractant expression.  Transplantation. 1998;  65 465-472
    PubMedGoogle Scholar
  • 94 Oya H, Sato Y, Ichida T et al.. Changes in serum cytokine levels and donor-specific transfusion via portal vein during the early period following living related donor liver transplantation.  Transplant Proc. 2003;  35 409
    CrossrefPubMedGoogle Scholar
  • 95 Takeuchi T, Lowry R P, Konieczny B. Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance Transplantation.  1992;  53 1281-1294
    PubMedGoogle Scholar
  • 96 Bugeon L, Cuturi M C, Hallet M M, Paineau J, Chabannes D, Soulillou J P. Peripheral tolerance of an allograft in adult rats-characterization by low interleukin-2 and interferon-gamma mRNA levels and by strong accumulation of major histocompatibility complex transcripts in the graft.  Transplantation. 1992;  54 219-225
    PubMedGoogle Scholar
  • 97 Josien R, Doullard P, Guillot C et al.. A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance.  J Clin Invest.. 1998;  102 1920-1926
    PubMedGoogle Scholar
  • 98 Inuzuka S, Koga S, Nishikido M et al.. Donor-specific blood transfusion prolongs cardiac allograft survival in rats by low nitric oxide production and elevated serum levels of prostaglandin E2 .  Immunology Letters. 2002;  83 119-124
    CrossrefPubMedGoogle Scholar
  • 99 Langrehr J M, Dull K E, Ochoa J B et al.. Evidence that nitric oxide production by in vivo allosensitized cells inhibits the development of allospecific CTL Transplantation.  1992;  53 632-640
    PubMedGoogle Scholar
  • 100 Ichiguchi O, Yamaguchi Y, Goto M et al.. A significant reduction of macrophages expressing inducible nitric oxide synthase in rat hepatic allografts pretreated with donor-specific blood.  Transplantation. 1998;  65 776-785
    PubMedGoogle Scholar
  • 101 Rodiles M, Chadee K. Novel regulation of cyclooxygenase-2 expression and prostaglandin E2 production by IFN-gamma in human macrophages.  J Immunol. 1998;  161 2441-2448
    PubMedGoogle Scholar
  • 102 Koga S, Luke P P, Specht S M et al.. Inhibition of the allograft response by donor specific blood transfusion: association with reduced local TH1 cytokines and nitric oxide but enhanced prostaglandin E2 production.  Transplantation. 2000;  70 1788-1796
    PubMedGoogle Scholar
  • 103 Plaut M, Marone G, Gillespie E. The role of cyclic AMP in modulating cytotoxic T lymphocytes. II. Sequential changes during culture in responsiveness of cytotoxic lymphocytes to cyclic AMP-active agents.  J Immunol. 1983;  131 2945-2952
    PubMedGoogle Scholar
  • 104 Betz M, Fox B S. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines.  J Immunol. 1991;  146 108-113
    PubMedGoogle Scholar
  • 105 Goto T, Herberman R B, Maluish A, Strong D M. Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity.  J Immunol. 1983;  130 1350-1355
    PubMedGoogle Scholar
  • 106 Kunkel S L, Chensue S W, Phan S H. Prostaglandins as endogenous mediators of interleukin 1 production.  J Immunol. 1986;  136 186-192
    PubMedGoogle Scholar
  • 107 Snyder D S, Beller D I, Unanue E R. Prostaglandins modulate macrophage Ia expression Nature.  1982;  299 163-165
    PubMedGoogle Scholar
  • 108 Shelby J, Marushack M M, Nelson E W. Prostaglandin production and suppressor cell induction in transfusion-induced immune suppression Transplantation.  1987;  43 113-116
    PubMedGoogle Scholar
  • 109 Yaron I, Jin M X, Oluwole S F, Hardy M A. Importance of the relative resistance of cord blood CD34+ cells to UVB in bone marrow transplantation.  Transplant Proc. 1997;  29 739
    CrossrefPubMedGoogle Scholar
  • 110 Yu S, Tu Y, Flye M W. The shift of Th1/Th2 ratios induced by portal venous administration of UVB-treated donor spleen cells prolonged mouse cardiac allografts.  Transplant Proc. 1997;  29 1162
    CrossrefPubMedGoogle Scholar
  • 111 Anderson C B, Tyler J D, Sicard G A et al.. Pretreatment of renal allograft recipients with immunosuppression and donor specific blood.  Transplantation. 1984;  38 664-668
    PubMedGoogle Scholar
  • 112 Fehrman I, Groth C G, Lundgren G, Moller E. Improved renal graft survival in transfused uremics. A result of a number of interacting factors.  Transplantation. 1980;  30 324-327
    PubMedGoogle Scholar
  • 113 Ettenger R B, Kerman R, Arnett L et al.. Sensitization following donor specific transfusions for living-related renal transplantation.  Transplant Proc. 1983;  15 943
    PubMedGoogle Scholar
  • 114 Morris P J. Kidney transplantation, principles and practice. In: Fine RN, Bajaj G Renal Transplantation in Children. 5th ed. Philadelphia, PA; WB Saunders 2001 622
    Google Scholar
  • 115 Miura S, Okazaki H, Sato T, Amada N, Sakurada M. Successful renal transplantation in presensitized recipients with double-filtration plasmapheresis and 15-deoxyspergualin.  Transplant Proc. 1997;  29 350-351
    CrossrefPubMedGoogle Scholar
  • 116 Sato Y, Farges O, Buffello D, Hatakeyama K, Bismuth H. Impact of 70% partial hepatectomy on administration of donor leukocytes in cardiac transplantation in rats.  Transplant Proc. 1998;  30 3873-3875
    CrossrefPubMedGoogle Scholar
  • 117 Iwaki Y, Cecka J M, Terasaki P I. The transfusion effect in cadaver kidney transplants-yes or no.  Transplantation. 1990;  49 56-59
    PubMedGoogle Scholar
  • 118 Cicciarelli J S. UNOS Registry data: effect of transfusions. In: Terasaki PI Clinical Transplants. Los Angeles, CA; UCLA Tissue Typing Laboratory 1990 407
    Google Scholar
  • 119 Ahmed Z, Terasaki P I. Effect of transfusion. In: Terasaki PI, Cecka MJ Clinical Transplants, 1991. Los Angeles, CA; UCLA Tissue Typing Laboratory 1992: 305
    Google Scholar
  • 120 Chertow G M, Milford E L. Pre-transplant blood transfusion and cadaveric renal allograft outcome: data from the United Network of Organ Sharing (UNOS).  J Am Soc Nephol. 1995;  16 1077
    PubMedGoogle Scholar
  • 121 Opelz G, Vanrenter ghem Y, Kriste G et al.. Prospective evaluaton of pretransplant blood transfusions in cadaver kidney recipients.  Transplantation. 1997;  63 964-967
    PubMedGoogle Scholar
  • 122 Alexander J W, Light J A, Donaldson L A et al.. Evaluation of pre- and posttransplant donor specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative clinical trials in transplantation research group.  Transplantation. 1999;  68 1117-1124
    PubMedGoogle Scholar

Maria SiemionowM.D. Ph.D. D.Sc. 

Department of Plastic Surgery, A60 The Cleveland Clinic Foundation

9500 Euclid Avenue, Cleveland, OH 44195